{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,005.00",
    "chg": -29,
    "chgp": "-2.8%",
    "dir": -1,
    "prev_price": "1,034.00",
    "mcapval": "5,194.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE191A01027",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "86.63 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter",
        "link": "https://news.google.com/rss/articles/CBMi_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?oc=5",
        "imagepath": "",
        "date": "2026-05-26 10:18:04",
        "description": "Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter  Business Standard..."
      },
      {
        "title": "Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-26 10:04:26",
        "description": "Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore  Business Standard..."
      }
    ],
    "total": 2,
    "sid": "653435",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "caption": "Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited And Orchid Pharma Limited",
      "datetime": "12-Jun-2026",
      "details": "Update for receipt of copy of order related to scheme of Amalgamation of Dhanuka Laboratories limited and Orchid Pharma limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "11-Jun-2026",
      "details": "Disclosure regarding the order passed by Goods and Service Department.",
      "source": "BSE"
    },
    {
      "caption": "Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Amalgamated Company) And Their Respective Shareholders And Creditors (The Scheme) Under Regulation 30 Of SEBI (Listing Obligati",
      "datetime": "05-Jun-2026",
      "details": "In continuation to our earlier intimation dated March 18 2026 with respect to merger petition we would like to inform that Honble National Company Law Tribunal (NCLT) on June 05 2026 i.e. today has allowed our petition sanctioning the scheme of Amalgamation and Arrangement of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors by virtue of which the Amalgamating Company would stand transferred to and vested in or deemed to have been transferred and vested in Amalgamated Company on a going concern basis.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter

2026-05-26 10:18:04

Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter Business Standard...

Read More

Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore

2026-05-26 10:04:26

Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore Business Standard...

Read More

View All News